The US Dollar Index, which measures the greenback against a basket of major currencies, was largely unchanged in Asia hours after modest gains in the previous session. The US Dollar Index Futures were ...

Investing.com-- OpenAI launched ChatGPT Go in India on Tuesday, its cheapest AI subscription tier to date as the company ...

MONTREAL/TORONTO (Reuters) -Air Canada flight attendants extended their strike into a fourth day on Tuesday, although the union said both sides had resumed talks as hundreds of thousands of passengers ...

In this episode, I talk about a surprising chart I saw recently, showing a surprising economic shift: consumer spending, once the bedrock of U.S. growth, is declining — while AI ...

Intel (NASDAQ: INTC) stock rose 5.4% after the Japanese tech conglomerate Softbank (OTC: SFTBY) agreed to buy $2 billion worth of stock in the beleaguered chipmaker with the goal of building advanced ...

Investing.com -- TEGNA (NYSE: TGNA) Inc. (NYSE:TEGNA) stock rose 2.8% after Nexstar Media Group (NASDAQ: NXST) announced it will acquire the broadcast company for $6.2 billion in an all-cash ...

Investing.com -- Robinhood Markets (NASDAQ: HOOD) stock rose on Tuesday, while competitors DraftKings (NASDAQ: DKNG) fell 2.4% and Flutter Entertainment (LON: FLTRF) (NYSE:FLTR) dropped 1% following ...

William Blair initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with an Outperform rating, given company’s dominant role as a one-stop services partner for the biopharma industry and potential ...

Investing.com -- Novo Nordisk and Eli Lilly (NYSE: LLY) shares edged higher Tuesday following results from Viking Therapeutics’ Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo ...

Investing.com -- Poland’s energy ministry announced plans on Tuesday to reinstate requirements for power companies to sell the majority of their electricity on the country’s power exchange, aiming to ...

Investing.com -- Danish drugmaker Novo Nordisk (NYSE: NVO) announced Tuesday that Canada’s health regulator has approved its diabetes drug Ozempic for additional uses related to kidney disease.

Investing.com -- RBC (TSX: RY) Capital Markets has reaffirmed its bullish stance on Centrica (LON: CNA) following the company ...